Masonic Medical Research Institute will host its first telethon Tuesday, Oct. 6, 2026, streaming live across the institute's ...
PRKAG2 syndrome is an autosomal dominant Atrium Therapeutics has received clearance from the US Food and Drug Administration ...
Atrium Therapeutics, Inc. (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics to the heart, announced today that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results